Next Article in Journal
Integrating Deep Supervised, Self-Supervised and Unsupervised Learning for Single-Cell RNA-seq Clustering and Annotation
Next Article in Special Issue
Carrot Anthocyanins Genetics and Genomics: Status and Perspectives to Improve Its Application for the Food Colorant Industry
Previous Article in Journal
Transcriptional Profiling of Normal, Stenotic, and Regurgitant Human Aortic Valves
Previous Article in Special Issue
Molecular Mechanism Underlying Mechanical Wounding-Induced Flavonoid Accumulation in Dalbergia odorifera T. Chen, an Endangered Tree That Produces Chinese Rosewood
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 11
Issue 7
10.3390/genes11070791
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A New Strategy to Increase Production of Genoprotective Bioactive Molecules from Cotyledon-Derived Silybum marianum L. Callus

by
Dina Gad
1,2,
Mahmoud Elhaak
3,
Andrea Pompa
4,
Magdy Mattar
2,
Mohamed Zayed
2,
Daniele Fraternale
4,* and
Karl-Josef Dietz
1,*
1
Biochemistry and Physiology of Plants, Faculty of Biology W5, Bielefeld University, 33501 Bielefeld, Germany
2
Faculty of Science, Botany Department, Menoufia University, Shebin EL-koum, Egypt
3
Faculty of Science, Botany Department, Tanta University, Tanta, Egypt
4
Department of Biomolecular Sciences, University of Urbino “Carlo Bo” Via Donato Bramante, 28, 61029 Urbino (PU), Italy
*
Authors to whom correspondence should be addressed.
Genes 2020, 11(7), 791; https://doi.org/10.3390/genes11070791
Submission received: 28 May 2020 / Revised: 7 July 2020 / Accepted: 9 July 2020 / Published: 14 July 2020
(This article belongs to the Special Issue Genetic and Molecular Mechanisms in Plant-Derived Compounds for Industrial Purposes)
Browse Figures
Versions Notes

Abstract

:
There is a need to enhance the production of bioactive secondary metabolites and to establish new production systems, e.g., for liver-protective compounds of Silybum marianum seeds. Quantifying and identifying the produced phytochemicals, and examining their protective effects against genotoxic agents, is of great interest. This study established a protocol for the qualitative and quantitative production of hepatoprotective compounds in cotyledon-derived Silybum marianum callus through optimized supplementation of the MS medium with the growth regulators 2,4-D, benzylaminopurine, myoinositol, and asparagine. High-performance liquid chromatography (HPLC) coupled with electrospray ionisation mass spectrometry (ESI-MS) allowed for identification and quantification of the produced compounds. None of the growth medium combinations supported a detectable production of silymarin. Instead, the generated calli accumulated phenolic acids, in particular chlorogenic acid and dicaffeoylquinic acid, as revealed by HPLC and mass spectrometric analysis. 4-Nitro-o-phenylenediamine (NPD) was employed in the AMES-test with Salmonella typhimurium strain TA98 because it is a potent mutagen for this strain. Results revealed that callus extract had a high anti-genotoxic activity with respect to standard silymarin but more evident with respect seed extract. The callus produced chlorogenic acid and dicaffeoylquinic acid, which revealed higher bioactivity than silymarin. Both compounds were not formed or could not be detected in the seeds of Silybum marianum Egyptian ecotype.

1. Introduction

Silybum marianum L. Gaertn (Asteraceae) is an annual to biennial herb originating from the Mediterranean and North African regions [1]. Currently it grows wild throughout Europe, North Africa, the Americas, and Australia [2]. The flower heads of the plant are mostly purple or white. S. marianum plants flower from June to August in the Northern or December to February in the Southern Hemisphere. S. marianum fruits vary from white to nearly black [3]. The medicinal part of the plant is the seeds [4].
Silybum marianum, commonly known as milk thistle, is one of the most important and best-researched plants of old times for the treatment of liver and gallbladder disorder, including hepatitis, cirrhosis, jaundice, and supportive therapy against Amanita phalloides mushroom intoxication and other toxins [5]. S. marianum fruits extract has been used for centuries as a “liver tonic” and is well known to prevent or reverse hepatotoxicity of reactive drug metabolites or naturally occurring toxins [3]. The main active compounds of milk thistle are silymarin and phenolic acids [6,7]. Silymarin, the active component of this plant, is a standardized extract comprised of roughly 70 to 80% silymarin flavonolignans (silybin A and B, isosilybin A and B, silydianin, and silychristin) and flavonoids (taxifolin and quercetin), and the remaining 20–30% are comprised of polymeric and oxidized polyphenolic compounds [8]. Silymarin has a wide range of biological and pharmacological effects including antioxidant activity [9]. Silymarin stimulates protein synthesis and cell regeneration in liver cells making it helpful in treating toxic liver damage, chronic inflammatory liver diseases, and liver cirrhosis [10,11]. It is also reported to exert anticancer activity against some human carcinoma cell lines [12,13]. Plant tissue culture has been developed as a powerful method for in vitro production of plant secondary metabolites under controlled conditions independent on environmental fluctuations [14,15]. Manipulation of culture medium composition can substantially increase the production of secondary compounds [16,17]. Major limitations of S. marianum cell cultures come from their instability during long-term culture and low product yield [15]. In this respect, tissue culture systems of S. marianum have been established using cotyledon explants [18]. Optimization is particularly useful when the precursors are expensive. In this respect, several products were found to accumulate in cultured cells to a higher level than in native plants through optimized cultural conditions.
Most secondary metabolites are derived from wild or cultivated plants, as their chemical synthesis is either extremely difficult or economically impossible [19]. Silybum marianum plants contain flavonoids, phenols, and tannins, while saponins and alkaloids are not detected. Contents of phenol and tannins are noted very less as compared to flavonoid i.e., 0.430% phenol is recorded in blue flowering and 0.4321% in the white flowering plant [20]. Callus cultures of S. marianum are widely known to produce saponins [21]. Plant extracts of saponins exhibit specific pharmacological activities to control many diseases, including hepatoprotective activity [22,23]. The protective activity of the total saponins from Actinidia valvata Dunn root (TSAV) was studied against carbon-tetrachloride- (CCl4-) induced acute liver injury in mice [24]. Total saponins of A. valvata Dunn root are known to be important pharmacologically active constituents against inflammation and tumor [25,26].
In vitro plant cultures can be used as natural sources of phenolic compounds for a sustainable use. Unlike plant tissues, the concentration and individual profile of phenolic compounds can be regulated in plant cultures leads to a standardized product [27,28]. Phenolic acids in fruits, vegetables, and other plants have been identified repeatedly as natural antioxidants. Chlorogenic acid (CGA) is a type of polyphenol which widely distributed in plants, but few commercial standards are available, therefore precise identification of individual CGA in complex mixtures is difficult. However, it is possible to differentiate between each isomer on the basis of its fragmentation patterns and chromatographic resolution of a reversed phase packing [29]. CGA exhibits pharmacological activities against inflammation, diabetes, tumors and ulcers [30,31].
As mentioned above silymarin exhibits diverse beneficial properties such as preventing or decelerating cancer development, counteracting apoptosis, and as antioxidant or hepatoprotectant [32]. Interestingly, the first reports also describe the anti-genotoxic properties of silymarin. The identification of substances that cause or protect from genotoxicity is of significant general interest [33]. Thus, the chemo-protective activity of silymarin is of high significance and more detailed investigations are highly recommended. Plants are a promising source for secondary metabolites with anti-mutagenic activity. Such anti-mutagens help, for example, by stimulating the cell defense against environmental mutagens. An increasing interest is directed to natural compounds that counteract diseases [34]. Various classes of secondary metabolites are present in the plants and exhibiting anti-mutagenic activities.
The Salmonella typhimurium revertant assay (Salmonella test; Ames test) is a widely accepted short-term bacterial assay for identifying substances with mutagenic activity. The Ames test is a mutagenesis test based on the detection of DNA mutations in a bacterium that is histidine-dependent. The used strain of Salmonella typhimurium TA 98 is auxotroph for histidine (His−) and can revert spontaneously to His+, and thus grow in a histidine-free medium. The very low spontaneous reversion rate can be increased by mutagens, which allows the mutagenic potential quantification of these substances. Such mutated cells can grow in the absence of histidine and form colonies. Therefore, the test is often referred to as “reversion assay”. The Salmonella mutagenicity test was particularly intended to identify chemically affected mutagenesis [35]. The test is utilized worldwide as an initial screen to evaluate the mutagenic capability of new chemicals, medications and environmental mutagens [36].
The aims of this study are to establish a protocol for high yield production of secondary metabolites that have medical importance for liver protection in cultured tissues of S. marianum. It was sought to compare the anti-genotoxic and chemo-protective effects of standard silymarin, silymarin extracted from Silybum marianum seeds and compounds produced by S. marianum cotyledons callus.

2. Material and Methods

2.1. Callus Culture

Silybum marianum seeds were collected from purple flower plants naturally growing in a neglected area in Gharbiya district (Nile Delta of Egypt) during the 2013–2014 growing season. Seeds were washed several times with distilled water. Following seed coat removal, the two cotyledons were separated from each other, and disinfected prior to starting the in vitro cultures. All steps took place in a laminar flow chamber. Sterilized cotyledons were cultured on a solidified Murashige and Skoog (MS) basal medium. Solidified basal MS media were supplemented with different concentrations of 2,4-D, Asn, BAP, and inositol producing 16 types of media labelled with alphabetical letters from A through O (Table 1). All cultures were incubated in the growth chamber at 25±2 °C in darkness for 2 months during which callus was transferred to a new medium after 21 d interval (at 21, 42, and 63 d). Then the harvested callus were dried at 40 °C, powdered and kept in plastic cups in a refrigerator.

2.2. Callus Extract for Chemical Analysis

Silybum marianum callus were collected at 63 day for biochemical analysis and dried samples were extracted with ethanol for spectrophotometric quantification of total flavonoids, phenolic compounds, and saponin. For HPLC and MS analysis, dried residue was dissolved in methanol (1 mL) and stored at 4 °C in the dark. Extracted samples were filtered before use for HPLC analysis.

2.3. Estimation of Flavonoids

The modified colorimetric method with aluminum chloride [37] was used to estimate the flavonoid content in callus extracts. A dried callus sample (100 mg) was extracted with 80% ethanol. A defined volume (0.5 mL) was mixed with 1.5 mL of 95% (v/v) ethanol, 0.1 mL of 10% (w/v) AlCl3, 0.1 mL of 1 M K-acetate and 2.8 mL water. After incubation at room temperature for 30 min, the absorbance was measured at 415 nm with a spectrophotometer (Cary 300, version 9, Agilent, Santa Clara, CA, USA). The same volume of water substituted for the AlCl3-solution in the blank. Quercetin was used as standard for calibration. Flavonoid content was calculated as mg quercetin equivalents/g dry weight (DW) callus.

2.4. Estimation of Saponin

The saponin content was quantified in callus powder; 100 mg was extracted with 85% ethanol (v/v). The clear supernatants were combined and adjusted to a defined volume. 0.1 mL of ethanol extract was diluted by adding 0.4 mL ethanol 85% (v/v) and then mixed with 0.5 mL of 8% (w/v) vanillin in ethanol. The solution was placed in an ice bath and mixed with 5 mL of 72% sulfuric acid, then heated to 60 °C for 10 min followed by cooling in ice-cold water. The absorbance of the formed color was measured at 544 nm. The standard curve was obtained with cholesterol. Saponin content is given as mg cholesterol equivalents/g DW callus [38].

2.5. Total Phenolic Compounds

Dry callus (100 mg) was extracted with 85% (v/v) ethanol. Ethanol extract (0.1 mL) was diluted up to 1 mL with distilled water and mixed with 0.1 mL Folin–Ciocalteu reagent and 1 mL Na2CO3 (20% w/v), and adjusted to 5 mL with distilled water. Absorbance was measured spectrophotometrically at 650 nm after exactly 30 min. A standard curve was constructed using pyrogallol. Total phenolic compounds content is given in mg pyrogallol equivalents/g DW callus [39].

2.6. HPLC Analysis

Silymarin standard solution was prepared from standardized silymarin (Sigma, Germany) by dissolving it in methanol to a concentration of 1 mg/mL. For chromatography, 20 μL of this standard solution or the callus-derived solutions were injected into the HPLC system Lichro Cart at a column temperature of 40 °C, using an RP-18 column (4 × 250 mm, 5 μm) (Merck, D-6100 Darmstadt, Germany). Gradient elution was applied at a flow rate of 1 mL min−1. The mobile phase A consisted of water containing 0.1% formic acid, while methanol was used as mobile phase B. The gradient condition was as follows: start 25% A and 75% B, 0–39 min linear change to 55% A and 45% B, 39–40 min linear change to 25% A and 75% B. Phenolic acids were detected at 288 nm.

2.7. Mass Spectrometry

The ESI-MS and MS/MS analysis were performed with an Esquire 3000 plus (Bruker Daltonics, Germany) using an ESI source with negative ion mode. The spray voltage was set to 4000 V. The temperature of the drying gas (N2) was kept at 180 ºC, the fractions of HPLC peaks were collected and evaporated using vacuum centrifuge, the residue was dissolved in MeOH (50% v/v) and the injection volume was 150 μL.

2.8. Bacterial Reverse Mutation Test (Ames Test)

The mutagenicity of NPD was determined in a bacterial reverse mutation assay using S. typhimurium tester strain TA98. Silymarin (SIGMA, Deisenhofen, Germany), callus and silybum marianum seed extracts were tested for protection against genotoxicity of NPD by the pre-incubation method [40]. Briefly, dry powders of callus and seeds (200 mg) were defatted using petroleum ether and extracted with 95% ethanol. Ethanol was evaporated at room temperature under a hood, and the extracted yellow powder was dissolved in 500 μL ethanol (95%) and the amount of callus peaks was evaluated by HPLC equivalent to dose 284 μg/plate, 1870 μg/plate of silymarin SIGMA and 226 μg/plate of seed extract. Then 50 μL of the stock culture of S. typhimurium TA98 was inoculated in 5 mL of Nutrient Broth medium including 5 μL ampicillin (40 mg/mL), 0.96 μL histidine (26 mM) and 0.5 mL biotin (0.5 mM). The mixture incubated with shaking at 37 °C for 16–18 h. Minimal-Agar plates were supplemented with 25× VBMM (Vogel-Bonner minimal medium) solution, 40% glucose and 40 μg/mL ampicillin. Before use, the plates were treated with 100 μL of 0.5 mM biotin. Agar-agar (6 g/L) dissolved in 1 mL distilled water was heated with 5 g/L NaCl after cooling to about 50 °C, 5 mL of a 0.5 mM histidine/biotin stock solution was added to 50 mL. The Ames test was prepared in 15 mL Greiner tubes containing 400 μL PBS, pH 7.5, mixed with 100 μL S. typhimurium working culture and 50 μL ± test compound (Silymarin or callus extract or seed extract). The culture was incubated at 37 °C for 1 h. After that, a 2 μL genotoxic compound NPD for mutation or 2 μL ethanol as negative control determination were added and incubated for 5 min. The mixture with 2 mL top agar was poured onto agar plates which were incubated at 37 °C for 48 h. After removing the plates from the incubator, colonies were counted with an electronic counter. The results are expressed as revertant colonies per plate. Data derived from six independent experiments.

2.9. Statistical Analysis

The obtained results were statistically assessed for the significance degree of variations using one and two way ANOVA [41]. All statistical methods were applied using the SPSS statistical software package.

3. Results and Discussion

3.1. Callus Culture and Production of Flavonoids, Phenolics, and Saponins

Calli of S. marianum grown in media A to O supplemented with different growth regulators [42] (Table 1) were analyzed for contents of the secondary metabolites saponins, phenolics, and flavonoids. Results (Table 2) depicts that the metabolite contents of the callus tentatively were in the order saponins > phenolics > flavonoids with means 36.3, 9.0, and 2.8 mg/g DW, respectively. This quantitative comparison should be taken with caution, because the metabolite groups were determined relative to standard reference compounds and, due to the diverse nature of similarly reacting compounds, could not be determined in absolute quantities by different methods. The three groups of compounds displayed the same pattern in the seeds of S. marianum but with significantly lower values (12.0, 6.0, and 0.6 mg/g DW respectively). However, callus produced 3.0-, 1.5-, and 4.6- times more saponins, phenolics, and flavonoids, respectively relative to the plant seeds. The most pronounced difference was in the flavonoids contents which correlate with the importance of S. marianum in treating liver diseases, including liver cirrhosis. The low concentrations of 2,4-D (0.25 mg/mL) combined with intermediate concentrations of Asn (50 mg/L), BAP (0.05 mg/L), and inositol (50 mg/L) as in media F produced the highest amount of flavonoids and phenolic compounds (4.7 and 16.0 mg/g respectively). In a converse manner, calli grown in intermediate 2,4-D concentrations (0.5 mg/mL) in the absence of Asn, BAP, and inositol (media H) accumulated the lowest amounts of flavonoids and phenolic compounds (0.7 and 3.0 mg/g respectively).
The best combination of growth regulators increased the contents of the two secondary compounds 5.3 and 6.7-times compared to the lowest contents. Callus growing in the presence of 0.5 mg/L 2,4-D with Asn (50 mg/L), BAP (0.05 mg/L) and inositol (50 mg/L) (media J) accumulated high amounts of saponins (53.0 mg/g DW). However the saponins compounds were absent in Silybum marianum plant [20] but their presence was recorded for seeds with 12 mg/g DW indicating that, the callus shows high potential for saponins accumulation that may increase its qualitative value for medical purposes. In a converse manner, 0.25 mg/L 2,4-D in the absence of Asn, BAP, and inositol (media D) produced the lowest amount of saponins (24.0 mg/g DW) that was double of the plant seeds. The total amounts of flavonoids, phenolic compounds, and saponins in S. marianum callus (48.1 mg/g DW) was 2.6-times (18.6 mg/g DW) that of seeds. However, accumulation of secondary metabolites in seeds was much lower than in all media calli grown particular, media F, I, and J.
Results revealed that S. marianum callus may serve as an alternative source for liver-protective pharmacological drugs and thus callus-based approaches would be of significant interest for economic and ecological reasons. The callus induction from cotyledons was strongly affected by endogenous and exogenous factors as represented in the present study. Medium supplementation with mineral elements, growth regulators, amino acids and vitamins is known to influence callus induction and growth rate in addition to its potential for secondary metabolites accumulation [43,44,45]. The use of 2,4-D alone or in combination with amino acids or other hormones has become a common approach in promoting cell culture or callus formation and inducing somatic embryogenesis in seed culture [46,47,48].

3.2. HPLC and Mass Spectrometric Analysis

The nature of the compounds, extracted from callus and seeds as well as standard silymarin, was identified by HPLC separation followed by mass spectrometry. Mostly similar peaks were revealed for standard silymarin and seeds extract (Figure 1A,B). Silybin A, silybin B, isosilybin A, isosilybin B, silydianin, and silychristin are the main constituents and silybin A and B are considered as biologically most active components among the silymarin constituents [49]. The compounds were identified by their retention time and mass at 481 m/z are in line with the reported data [50]. The peaks area indicated that the used Egyptian ecotype Silybum marianum with purple flower contained low amounts of silybin A and B compared to standard silymarin.
The callus extracts separated into different peaks with two dominant ones in the UV-spectrum of callus that were missing in standard silymarin and seed extract. The first peak eluted after 7.7 min in the HPLC chromatogram (Figure 1C).
ESI-MS and MS/MS identified the compound as chlorogenic acid (CGA), based on its mass of 353 m/z and the fragment mass of 190.9 m/z in the MS/MS-mode (Figure 2). Both masses are in line with the reported data [51]. The second dominating peak eluted after 17.1 min and revealed an ESI-MS mass of 515.1 m/z and a main MS/MS fragment of 352.9 m/z (Figure 1 and Figure 2) which corresponds to the molecular mass of 3,5-O- dicaffeoylquinic acid (DCQ). Both masses matched with reported ones [52]. CGA and DCQ were quantified from peak areas by comparison with standard CGA and DCQ (Table 3), thus providing information on slightly higher yield of DCQ than of CGA in the callus in response to all medium growth regulators (media A to O). The data also show that medium I with medium concentrations of 2,4-D and low concentrations of Asn, BAP and, inositol produced the highest yield of both CGA and DCQ. Medium J produced the second highest yield, while medium H with medium concentrations of 2,4-D but lacking Asn, BAP and inositol produced very small amounts of the two acids. A variation of CGA and DCQ production by 29% (average of all results) was observed. The variation decreased with higher yield, e.g., in callus from medium I (16% and 18%, respectively). Such fluctuations in yield may indicate instability of production. It is worth mention that callus from all media displayed the same chromatographic pattern, but with different areas reflecting the metabolism of the different compounds in response to the applied growth regulators (Figure 3).
The results also revealed that none of the callus growth regulator combination supported production and transformation of flavonoids to silymarin fractions. Instead the callus synthesized chlorogenic acid and 3,5-O-dicaffeoylquinic acid. The accumulation of chlorogenic acid and 3,5-O-dicaffeoylquinic acid may indicate that the callus fails to express the metabolic genes needed for the conversion of both compounds in to silymarin. Cell cultures of S. marianum was also found to produce phenolic acids such as chlorogenic acid, isochlorogenic acid A, B, and C, trans-ferulic acid, 4-methoxy-cinnamic acid, and vanillic acid [7].
Chlorogenic acid is a precursor produced both in cells and callus cultures of S. marianum, in addition to cynarin. 3,5-O-dicaffeoylquinic acid is a double ester of caffeic acid. Quinic acid was produced only in the plant callus as a predominant phenolic compound. Caffeic acid is also synthesized by shikimic and phenylpropanoid pathway but take a different branch than flavonoids. The p-Coumaroyl-CoA can enter the flavonoid biosynthesis or alternatively can be converted to caffeoyl-CoA and coupled with quinic acid to form 5-O-caffeoylquinic acid [53].
The ability of calli grown from S. marianum cotyledons to accumulate CGA and CQA to high amounts is of pharmaceutically interesting since they are known for their positive effects on liver function. Likewise, chlorogenic acid exhibits a better therapeutic protective action than silymarin in CCl4 (carbon tetrachloride)-treated mice [54]. Isochlorogenic acids significantly improve the viability of hepatocytes at concentrations of 1 to 100 μg/mL that afforded much stronger liver protection than the reference drug silybinin at 100 μg/mL concentration [55].
Interestingly, the callus biomass production did not reveal the expected negative correlation with phenolics including CGA+DCQ accumulation, but rather a slightly positive dependency was remarked. Often synthesis of defense compounds negatively affects biomass production as tradeoff, which is not observed in the present study. However, medium I produced the greatest callus weight [42] as well as the highest contents of CGA+DCQ. Thus, the well-growing callus conditions tended to produce slightly more CGA+DCQ.
Only detailed HPLC analyses coupled with mass spectrometric identification is reliable for the compounds of silymarin detection as illustrated in the present study. The assay for silymarin compounds based on 2,4-dinitrophenylhydrazine which reacts with carbonyl groups of ketones and aldehydes, is not reliable for silymarin detection, as proved by our previous study which estimated such phenolic compounds spectrophotometrically and considered it as silymarin [42]. Thus, despite the fact that it has been repeatedly used to spectrophotometrically assess silymarin contents of S. marianum tissues and extracts [56], such data must be considered with care. This study confirms that phenolic compounds such as chlorogenic acid and dicaffeoylquinic acid are also react with the reagent 2,4-dinitrophenylhydrazine.

3.3. Anti-Genotoxicity Effects of Callus Extract

The AMES assay was employed to assess the protection against a standard mutagen in Salmonella typhimurium TA 98, OPD, of callus extracts in comparison with that of standard silymarin and S. marianum seed extract (Figure 4). Figure 4 shows that callus extract recorded the highest protection against NPD of 45.2% at a dose of 284 μg/plate in comparison with standard silymarin that reduced the genotoxicity of the NPD by 42.8% at a higher dose of (1870 μg/plate) (normalized to chlorogenic acid) as determined by the decreasing number of His+ revertants. Seed extract caused the least effect on NPD (by 35.8% at a dose of 226 μg/plate).
The S. marianum callus extract strongly decreased the rate of reverse mutations induced by S. typhimurium TA98 by 45.2% at dose 284 μg/plate. This indicate that the recorded compounds in the callus extract (CGA and DCQ) acquired a greater effect than standard and silymarin components from seeds. Caffeic acid and chlorogenic acid were found to suppress the mutagenic action of N-methyl-N-nitro-nitrosoguanidine in S. typhimurium strain TA 1535 by scavenging electrophilic degradation products of the cancer-causing agents [57,58]. In this regard, Silymarin at dose 1000 μg/plate reduced the genotoxicity of DMH, AOM and MNU agents in a dose-dependent manner and the number of His+ revertants per plate decreased by 50% at the highest dose of silymarin [59]. Both intracellular and extracellular systems contribute to the activity of phenolics against mutagens [60,61].

4. Conclusions

Media optimization through different concentrations of growth regulators 2,4-D, benzylaminopurine, myoinositol, and asparagine failed to support the production of flavonlignans of the complex silymarin production in the cells. However, instead the callus synthesized chlorogenic acid and 3,5-O-dicaffeoylquinic acid that have anti-genotoxic activity that suppresses the mutagenic action of 4-nitro-o-phenylenediamine in Salmonella typhimurium TA98. This study provides the experimental framework for the bioproduction of the two medicinal compounds from Silybum marianum cotyledon callus.

Author Contributions

D.G. and M.E. conceived the study; D.G., M.E. and K.-J.D. designed the study. K.-J.D. contributed the analytical tools. D.G. conducted the experiments and drafted the manuscript. A.P., D.F., D.G., M.E., M.M. and K.-J.D. M.Z. interpreted and discussed the results, and wrote, read and agreed on the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no specific grant from funding agencies in the public, commercial or non-profit sectors, but was supported by funding from the Universities where it was performed.

Acknowledgments

D.G. acknowledges support by mission sector of Egyptian ministry of high education.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Boulos, L. Flora of Egypt; Al Hadara Publishing Inc.: Cairo, Egypt, 2000; pp. 125–182. [Google Scholar]
  2. Parsons, W.T.; Cuthbertson, E.G. Noxious Weeds of Australia, 2nd ed.; Angus & Robertson: Sydney, Australia, 2001. [Google Scholar]
  3. Svoma, E. Studies on the embryology and gynoecium structures in Drimys winteri (Winteraceae) and some Annonaceae. Plant Syst. Evol. 1998, 21, 205–229. [Google Scholar] [CrossRef]
  4. Anthony, K.L.; Saleh, M.A. Free Radical Scavenging and Antioxidant Activities of Silymarin Components. Antioxidants 2013, 2, 398–407. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Pradhan, S.C.; Girish, C. Hepatoprotective herbal drug, silymarin rom experimental pharmacology to clinical medicine. Indian J. Med. Res. 2006, 124, 491–504. [Google Scholar] [PubMed]
  6. Pepping, J. Milk Thistle: Silybum marianum. Am. J. Health Syst. Pharm. 1999, 56, 1195–1197. [Google Scholar] [CrossRef] [PubMed]
  7. Riedel, H.; Cai, Z.; Kutuk, O.; Smetanska, I. Obtaining phenolic acids from cell cultures of various Artemisia species. Afr. J. Biotechnol. 2010, 9, 8805–8809. [Google Scholar]
  8. Kren, V.; Walterova, D. Silybin and silymarin new effects and applications. Biomed. Papers. 2005, 149, 29–41. [Google Scholar] [CrossRef] [Green Version]
  9. Koksal, E.; Gulcin, I.; Beyza, S.; Sarikaya, O.; Bursal, E. In vitro antioxidant activity of silymarin. J. Enzyme Inhib. Med. Chem. 2009, 24, 395–405. [Google Scholar] [CrossRef] [Green Version]
  10. Fraschini, F.; Demartini, G.; Esposti, D. Pharmacology of silymarin. Clin. Drug Investig. 2002, 22, 51–65. [Google Scholar] [CrossRef]
  11. Saller, R.; Meier, R.; Brignoli, R. The use of silymarin in the treatment of liver diseases. Drugs 2001, 61, 2035–2063. [Google Scholar] [CrossRef]
  12. Singh, R.P.; Aggarwal, R. Prostate cancer prevention by silibinin. Curr. Cancer Drug Targets 2004, 4, 1–11. [Google Scholar] [CrossRef]
  13. Yang, S.H.; Lin, J.K.; Chen, W.S.; Chiu, J.H. Antiangiogenic effect of silymarin on colon cancer LoVo cell line. J. Surg. Res. 2003, 113, 133–138. [Google Scholar] [CrossRef]
  14. Sa, G.; Mi, M.; He-chun, Y.; Ben-ye, L.; Guo-Feng, L.; Kang, C. Effect of ipt gene expression on the physiological and chemical characteristics of Artemisia annua L. Plant. Sci. 2001, 160, 691–698. [Google Scholar] [CrossRef]
  15. Bonhomme, V.; Laurain-Matter, D.; Lacoux, J.; Fliniaux, M.A.; Jacquin-Dubreuil, A. Tropane alkaloid production by hairy roots of Atropa belladonna obtained after transformation with Agrobacterium rhizogenes15834 and Agrobacterium tumefaciens containing rol A, B, C genes only. J. Biotechnol. 2000, 81, 151–158. [Google Scholar] [CrossRef]
  16. Cacho, M.; Moran, M.; Corchete, P.; Fernandez-Tarrago, J. Influence of medium composition on the accumulation of flavonolignans in cultured cells of Silybum marianum (L.) Gaertn. Plant. Sci. 1999, 144, 63–68. [Google Scholar] [CrossRef]
  17. Hagendoorn, M.J.M.; Wagner, A.M.; Segers, G.; Van der Plas, L.H.W.; Oostdam, A.; Van Walraven, H.S. Cytoplasmic acidification and secondary metabolite production in different plant cell suspensions. Plant. Physiol. 1994, 106, 723–730. [Google Scholar] [CrossRef] [Green Version]
  18. Cimino, C.; Cavalli, S.V.; Spina, F.; Natalucci, C.; Priolo, N. Callus culture for biomass production of Milk thistle as a potential source of milk clotting peptidases. Electron. J. Biotechnol. 2006, 9, 238–240. [Google Scholar] [CrossRef] [Green Version]
  19. Doernenburg, H.; Knorr, D. Strategies for the improvement of secondary metabolite production in plantcell cultures. Enzym. Microb. Technol. 1995, 17, 674–684. [Google Scholar] [CrossRef]
  20. Shah, S.M.M.; Khan, F.A.; Shah, S.M.H.; Chishti, K.A.; Pirzada, S.M.S.S.; Khan, M.A. Evaluation of phytochemicals and antimicrobial activity of white and blue capitulum and whole plant of Silybum marianum. World Appl. Sci. J. 2011, 12, 1139–1144. [Google Scholar]
  21. Ahmed John, S.; Koperuncholan, M. Direct Root Regeneration and Indirect Organogenesis in Silybum marianum and Preliminary Phytochemical, Antibacterial Studies of Its Callus. Int. J. Pharm. 2012, 2, 52–57. [Google Scholar]
  22. Huang, Q.F.; Zhang, S.J.; Zheng, L.; He, M.; Huang, R.B.; Lin, X. Hepatoprotective effects of total saponins isolated from Taraphochlamys affinis against carbon tetrachloride induced liver injury in rats. Food Chem. Toxicol. 2012, 50, 713–718. [Google Scholar] [CrossRef]
  23. Rastogi, S.; Pandey, M.M.; Rawat, A.K.S. An ethnomedicinal, phytochemical and pharmacological profile of Desmodium gangeticum (L.) DC. and Desmodium adscendens (Sw.) DC. J. Ethnopharmacol. 2011, 136, 283–296. [Google Scholar] [CrossRef] [PubMed]
  24. Qu, L.P.; Xin, H.L.; Zheng, G.Y. Hepatoprotective activity of the total saponins from Actinidia valvata dunn root against carbon tetrachloride-induced liver damage in mice. Evid.-Based Complement. Alternat. Med. 2012, 216061, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Zhang, Y.N.; Liu, L.; Ling, C.Q. Inhibition effect of active fraction from Actinidia valvata on growth of transplanated mouse tumor cells and preliminary study of its mechanism. Zhongguo Zhongyao Zazhi 2006, 31, 918–920. [Google Scholar] [PubMed]
  26. Yi, T.J.; Xu, Y.F.; Zheng, G.; Zheng, Y.; Xin, H.L.; Ling, C.Q. Inhibitory effects of total saponin from Actinidia Valvata on murine transplanted tumor. Chin. Arch. Tradit. Chin. Med. 2009, 27, 1642–1643. [Google Scholar]
  27. Murthy, H.N.; Dandin, V.S.; Zhong, J.J.; Paek, K.Y. Strategies for enhanced production of plant secondary metabolites from cell and organ cultures. In Production of Biomass and Bioactive Compounds Using Bioreactor Technology; Paek, K.Y., Murthy, H.N., Zhong, J.J., Eds.; Springer: Dordrecht, The Netherlands, 2014; pp. 471–508. [Google Scholar]
  28. Moreno, P.R.H.; van der Heijden, R.; Verpoorte, R. Cell and tissue cultures of Catharanthus Roseus: A literature survey. Plant. Cell Tissue Organ. Cult. 1995, 42, 1–25. [Google Scholar] [CrossRef]
  29. Clifford, M.N.; Kirkpatrick, J.; Kuhnert, N.; Roorendaal, H.; Salgado, P.R. LC-MSn analysis of the cis isomers of chlorogenic acids. Food Chem. 2008, 106, 379–385. [Google Scholar] [CrossRef]
  30. Kim, J.; Jeong, I.H.; Kim, C.S.; Lee, Y.M.; Kim, J.M.; Kim, J.S. Chlorogenic acid inhibits the formation of advanced glycation end products and associated protein cross-linking. Arch. Pharm. 2011, 3, 495–500. [Google Scholar] [CrossRef]
  31. Yang, J.S.; Liu, C.W.; Ma, Y.S.; Weng, S.W.; Tang, N.Y.; Wu, S.H.; Ji, B.C.; Ma, C.Y.; Ko, Y.C.; Funayama, S.; et al. Chlorogenic Acid Induces Apoptotic Cell Death in U937 Leukemia Cells through Caspase- and Mitochondria-dependent Pathways. In Vivo 2012, 26, 971–978. [Google Scholar]
  32. Kidd, P.M. Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts. Altern. Med. Rev. 2009, 14, 226–246. [Google Scholar]
  33. Mortelmans, K.; Zeiger, E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455, 29–60. [Google Scholar] [CrossRef]
  34. Aydin, S.; Basaran, A.A.; Basaran, N. The protective effects of some phenylethanoid glycosides on the mitomycin c induced DNA strand breakage. Hacet. Univ. J. Fac. Pharm. 2004, 24, 1–11. [Google Scholar]
  35. Ames, B.N.; McCann, J.; Yamasaki, E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31, 347–364. [Google Scholar] [CrossRef]
  36. McCann, J.; Spingarn, N.E.; Kobori, J.; Ames, B.N. Detection of carcinogens as mutagens: Bacterial tester strains with R factor plasmids. Proc. Natl. Acad. Sci. USA 1975, 72, 979–983. [Google Scholar] [CrossRef] [Green Version]
  37. Chang, C.C.; Yang, M.H.; Wen, H.M.; Chern, J.C. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food Drug Anal. 2002, 10, 178–182. [Google Scholar]
  38. Hiai, S.; Oura, H.; Hamanaka, H.; Odaka, Y. A colour reaction of panaxadiol with vanillin and sulfuric acid. Planta Med. 1975, 28, 131–138. [Google Scholar] [CrossRef] [PubMed]
  39. Jindal, K.K.; Singh, R.N. Phenolic content in male and female Carica papaya: A possible physiological marker for sex identification of vegetable seedlings. Physiol. Plant. 1975, 33, 104–107. [Google Scholar] [CrossRef]
  40. Maron, D.; Ames, B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113, 173–215. [Google Scholar] [CrossRef]
  41. Bishop, O.N. Statistics in Biology; Longman, Penguin: London, UK, 1983; pp. 56–63. [Google Scholar]
  42. Elhaak, M.; Zayed, M.; Mattar, M.; Gad, D.A.; Dietz, K.J. Optimization of Silybum marianum L. callus production and magnifying callus silymarin accumulation by elicitors or precursors. Int. J. Adv. Pharm. Biol. Chem. 2016, 5, 148–163. [Google Scholar]
  43. Stafford, A.; Morris, P.; Fowler, M.W. Plant cell biotechnology: A perspective. Enzym. Microb. Technol. 1986, 8, 19–23. [Google Scholar] [CrossRef]
  44. Namdeo, A.; Patil, S.; Fulzele, D.P. Influence of fungal elicitors on production of Ajmalicine by cell cultures of Catharanthus roseus. Biotechnol. Prog. 2002, 18, 159–162. [Google Scholar] [CrossRef]
  45. Monemi, M.B.; Kazemitabar, S.K.; Khaniki, B.G.; Yasari, E.; Sohrevardi, F.; Pourbagher, R. Tissue culture study of the medicinal plant leek (Allium ampeloprasum L.). Int. J. Mol. Cell. Med. 2014, 3, 119–125. [Google Scholar]
  46. Liu, M.C. Factors affecting induction, Somatic embryogenesis and Plant regeneration of calli from culture immature inflourescence of Sugarcane. J. Plant. Physiol. 1993, 141, 714–720. [Google Scholar] [CrossRef]
  47. Mordhorst, A.P.; Voerman, K.J.; Hartog, M.V.; Meijer, E.A.; Vanwent, J.; Koornneef, M.; Devries, S.C. Somatic embryogenesis in Arabidopsis thaliana is facilitated by mutations in genes repressing meristematic cell divisions. Genetics 1998, 149, 549–563. [Google Scholar] [PubMed]
  48. Benson, E.E. In vitro plant recalcitrance, an introduction. In Vitro Cell. Dev. Biol. Plant. 2000, 36, 141–148. [Google Scholar] [CrossRef]
  49. Kavasnica, F.; Biba, B.; Sevcik, R.; Voldrich, M.; Kratkta, J. Analysis of active components of silymarin. J. Chromatogr. A 2003, 990, 239–245. [Google Scholar] [CrossRef]
  50. Kuki, A.; Nagy, L.; Deak, G.; Nagy, M.; Zsuga, M.; Keki, S. Identification of silymarin constituents: An improved HPLC-MS method. Chromatographia 2012, 75, 175–180. [Google Scholar] [CrossRef]
  51. Li, Z.; Wang, L.; Yang, G.; Shi, H.; Jiang, C.; Liu, W.; Zhang, Y. Study on the determination of polyphenols in Tobacco by HPLC coupled with ESI-MS after solid-phase extraction. J. Chromatogr. Sci. 2003, 41, 36–40. [Google Scholar] [CrossRef]
  52. Plazonic, A.; Bucar, F.; Males, Z.; Mornar, A.; Nigovic, B.; Kujundzic, N. Indentification and quantification of flavonoids and phenolic acids in Burr Parsely (Caucalis platycarpos L.) using high performance liquid chromatography with Diode array detection and electrospray ionization mass spectrometry. Molecules 2009, 14, 2466–2490. [Google Scholar] [CrossRef] [Green Version]
  53. Niggeweg, R.; Michael, A.J.; Martin, C. Engineering plants with increased levels of the antioxidant chlorogenic acid. Nat. Biotechnol. 2004, 22, 746–754. [Google Scholar] [CrossRef]
  54. Kapil, A.; Koul, I.B.; Suri, O.P. Antihepatotoxic effects of chlorogenic acid from Anthocephalus cadamba. Phytother. Res. 1995, 9, 189–193. [Google Scholar] [CrossRef]
  55. Wu, Y.H.; Hao, B.J.; Shen, E.; Meng, Q.L.; Hu, M.H.; Zhao, Y. Protective properties of Laggera alata extract and its principle components against D-Galactosamine-injured Hepatocytes. Sci. Pharm. 2012, 80, 447–456. [Google Scholar] [CrossRef] [Green Version]
  56. Stoiljkavic, Z.Z.; Petrovic, S.D.; Ilic, B.S. Examination of localization of silymarin and fatty oil in Silybum marianum Gaertn. fruit. Chem. Ind. Chem. Eng. Q. 2007, 13, 55–59. [Google Scholar] [CrossRef]
  57. Chan, R.I.; San, R.H.; Stich, H.F. Mechanism of Inhibition of N-methyl-N’-nitro-N-nitrosoguanidine-induced Mutagenesis by Phenolic Compounds. Cancer Lett. 1986, 31, 27–34. [Google Scholar] [CrossRef]
  58. Yoshimoto, M.; Yahara, S.; Okuno, S.; Islam, S.; Ishiguro, K.; Yamakawa, O. Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweet potato (Ipomoea batatas L.) leaf. Biosci. Biotechnol. Biochem. 2002, 66, 2336. [Google Scholar] [CrossRef] [Green Version]
  59. Toyoda-Hokaiwado, N.; Yasui, Y.; Muramatsu, M.; Masumura, K.; Takamune, M.; Yamada, M.; Ohta, T.; Tanaka, T.; Nohmi, T. Chemopreventive effects of silymarin against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation-associated carcinogenicity and genotoxicity in the colon of gpt delta rats. Carcinogenesis 2011, 32, 1512–1517. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. De Flora, S. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 1998, 402, 151–158. [Google Scholar] [CrossRef]
  61. De Flora, S.; Izzoti, A.; Agostini, D.F.; Balansky, B.M.; Noonan, D.; Albini, A. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat. Res. 2001, 480, 9–22. [Google Scholar] [CrossRef]
Genes 11 00791 g001 550
Figure 1. HPLC chromatograms of methanolic extracts. (a) Standard silymarin (SIGMA), (b) Silymarin from Silybum marianum seeds of the Egyptian cultivar, and (c) S. marianum callus derived from cotyledons. Absorbance of fractions was monitored at 288 nm. The separation was performed ≥ three times with similar result.
Figure 1. HPLC chromatograms of methanolic extracts. (a) Standard silymarin (SIGMA), (b) Silymarin from Silybum marianum seeds of the Egyptian cultivar, and (c) S. marianum callus derived from cotyledons. Absorbance of fractions was monitored at 288 nm. The separation was performed ≥ three times with similar result.
Genes 11 00791 g001
Genes 11 00791 g002 550
Figure 2. Fragmentation pattern of the peaks 1 (7.7 min) and 2 (17.1 min). (a) ESI-MS and MS/MS in the negative mode of the ion for peak 1 (7.7 min). The obtained m/z values reflect the molecular weight of chlorogenic acid (353). (b) ESI-MS and MS/MS (negative mode) of the ion for peak 2 (17.1 min). The obtained m/z value represent the molecular weight of 3,5-O-dicaffeoylquinic acid (515).
Figure 2. Fragmentation pattern of the peaks 1 (7.7 min) and 2 (17.1 min). (a) ESI-MS and MS/MS in the negative mode of the ion for peak 1 (7.7 min). The obtained m/z values reflect the molecular weight of chlorogenic acid (353). (b) ESI-MS and MS/MS (negative mode) of the ion for peak 2 (17.1 min). The obtained m/z value represent the molecular weight of 3,5-O-dicaffeoylquinic acid (515).
Genes 11 00791 g002
Genes 11 00791 g003 550
Figure 3. Quantitative HPLC analysis. Chlorogenic acid (height of dark grey bars) and 3,5-O-dicaffeoylquinic acid (light grey bars) were quantified in methanolic extract of S. marianum callus. Data are means from three independent experiments ± SE.
Figure 3. Quantitative HPLC analysis. Chlorogenic acid (height of dark grey bars) and 3,5-O-dicaffeoylquinic acid (light grey bars) were quantified in methanolic extract of S. marianum callus. Data are means from three independent experiments ± SE.
Genes 11 00791 g003
Genes 11 00791 g004 550
Figure 4. (A) Effect of callus extract on 4-nitro-o-phenylenediamine (NPD)-induced genotoxicity in S. typhimurium TA98 strain. (a) Spontaneously occurring revertants (–his media). (b) A high number of colony revertants in presence of NPD. (c) Lower number of colony revertants in NPD-treated TA98 in the presence of callus from Silybum marianum cotyledons. (B) Protection percentage of tested compounds (Callus extract, Silymarin SIGMA, and seed extract) against genotoxicity induced by 4-nitro-o-phenyldiamine (NPD). Callus extract, Silymarin SIGMA, and seed extract reduced genotoxicity of NPD by 45.2%, 42.8%, and 35.8% respectively. Data are means±SE from six independent experiments.
Figure 4. (A) Effect of callus extract on 4-nitro-o-phenylenediamine (NPD)-induced genotoxicity in S. typhimurium TA98 strain. (a) Spontaneously occurring revertants (–his media). (b) A high number of colony revertants in presence of NPD. (c) Lower number of colony revertants in NPD-treated TA98 in the presence of callus from Silybum marianum cotyledons. (B) Protection percentage of tested compounds (Callus extract, Silymarin SIGMA, and seed extract) against genotoxicity induced by 4-nitro-o-phenyldiamine (NPD). Callus extract, Silymarin SIGMA, and seed extract reduced genotoxicity of NPD by 45.2%, 42.8%, and 35.8% respectively. Data are means±SE from six independent experiments.
Genes 11 00791 g004
Table
Table 1. Experimental design and composition of callus growth media A to O. The table gives the levels of 2,4-D, asparagines, benzyladenine, and myo-inositol (mg/L).
Table 1. Experimental design and composition of callus growth media A to O. The table gives the levels of 2,4-D, asparagines, benzyladenine, and myo-inositol (mg/L).
2,4-D (mg/L)Asparagine (mg/L)Benzyladenine (mg/L)Myo-Inositol (mg/L)
0.025501000.00.010.050.10.02550100
0.00ABC0ABC0ABC
0.25DEFGDEFGDEFG
0.5HIJKHIJKHIJK
1.0LMNOLMNOLMNO
Table
Table 2. Effect of medium modifications on callus contents of flavonoids, phenolic compounds and saponins in comparison with the seeds’ contents. Each value represents the mean ± SE from six replicates. NI: No callus induction.
Table 2. Effect of medium modifications on callus contents of flavonoids, phenolic compounds and saponins in comparison with the seeds’ contents. Each value represents the mean ± SE from six replicates. NI: No callus induction.
Growth Regulators Level (mg/L)FlavonoidsPhenolic CompoundsSaponinTotal
Media Code2,4-DAsnBAPInositol(mg/g dw)
A0250.0125NINININI
B0500.05501.4 ± 0.2 c5 ± 0.6 bc33 ± 1 ab39.4
C01000.11004.2 ± 0.2 fg13 ± 0.9 hi32 ± 2 ab49.2
D0.250001.6 ± 0.2 c4 ± 0.7 ab24 ± 2 ab29.6
E0.25250.01254.4 ± 0.3 g14 ± 0.3 i33 ± 2 ab51.4
F0.25500.05504.7 ± 0.3 g16 ± 0.8 j42 ± 5 b62.7
G0.251000.11002.6 ± 0.1 d10 ± 1 g33 ± 2 ab35.6
H0.50000.7 ± 0.03 ab3 ± 0.7 a26 ± 1 ab29.7
I0.5250.01254.2 ± 0.4 fg12 ± 2.2 h32 ± 1 ab48.2
J0.5500.05503.8 ± 0.2 ef12 ± 1.1 gh53 ± 9 e68.8
K0.51000.11003.4 ± 0.1 e10 ± 1.6 g52 ± 16 e65.4
L10001.7 ± 0.03 c4 ± 1.4 ab27 ± 7 c31.0
M1250.01252.4 ± 0.1 d9 ± 1.2 f43 ± 4 d54.4
N1500.05501.3 ± 0.2 bc8 ± 0.5 ef46 ± 20 d55.3
O11000.11001.2 ± 0.2 bc6 ± 0.7 cd42 ± 2 b49.2
Mean content in callus2.8 ± 1.59.0 ± 2.136.3 ± 248.1
Mean content in seeds0.6 ± 0.036 ± 0.512 ± 418.6
F-value50.2460.27171.3
Probability p<0.000.000.00
Means in the same column have similar letter are significantly varied at p < 0.05.
Table
Table 3. Chlorogenic acid and dicaffeoylquinic acid contents of the two major peaks from S. marianum callus. Each value represents the mean ± SE from three replicates NI: No induction.
Table 3. Chlorogenic acid and dicaffeoylquinic acid contents of the two major peaks from S. marianum callus. Each value represents the mean ± SE from three replicates NI: No induction.
Peak 1: MS1 353, MS/MS 190.1Peak 2: MS1 515.1, MS/MS 352.9
Media CodeTR (min)Chlorogenic Acid (mg/g DW)TR (min)Dicaffeoylquinic Acid (mg/g DW)
ANINININI
B7.93.7 ± 1.1 bcde17.45.0 ± 1.6 abc
C7.96.3 ± 1.1 ef17.49.1 ± 2.5 cde
D7.93.5 ± 0.9 bcd17.23.5 ± 1.1 ab
E7.83.9 ± 1.0 cde17.210.7 ± 2.5 de
F7.84.2 ± 1.4 cde17.29.2 ± 1.7 cde
G7.81.7 ± 1.0 abc17.25.4 ± 1.6 abc
H7.70.8 ± 0.3 a17.11.7 ± 0.5 a
I7.77.2 ± 1.3 f17.111.3 ± 1.8 e
J7.75.2 ± 0.6 def17.16.1 ± 2.3 e
K7.72.2 ± 0.6 abc17.16.0 ± 1.4 abcd
L7.71.1 ± 0.5 ab17.12.5 ± 1.0 ab
M7.73.8 ± 0.8 cde17.07.2 ± 2.5 bcde
N7.71.8 ± 0.4 abc17.02.9 ± 0.6 ab
O7.72.4 ± 0.9 abc17.02.5 ± 0.9 ab
Mean7.83.4117.25.94
Means in the same column have similar letter are significantly varied at p < 0.05.

Share and Cite

MDPI and ACS Style

Gad, D.; Elhaak, M.; Pompa, A.; Mattar, M.; Zayed, M.; Fraternale, D.; Dietz, K.-J. A New Strategy to Increase Production of Genoprotective Bioactive Molecules from Cotyledon-Derived Silybum marianum L. Callus. Genes 2020, 11, 791. https://doi.org/10.3390/genes11070791

AMA Style

Gad D, Elhaak M, Pompa A, Mattar M, Zayed M, Fraternale D, Dietz K-J. A New Strategy to Increase Production of Genoprotective Bioactive Molecules from Cotyledon-Derived Silybum marianum L. Callus. Genes. 2020; 11(7):791. https://doi.org/10.3390/genes11070791

Chicago/Turabian Style

Gad, Dina, Mahmoud Elhaak, Andrea Pompa, Magdy Mattar, Mohamed Zayed, Daniele Fraternale, and Karl-Josef Dietz. 2020. "A New Strategy to Increase Production of Genoprotective Bioactive Molecules from Cotyledon-Derived Silybum marianum L. Callus" Genes 11, no. 7: 791. https://doi.org/10.3390/genes11070791

APA Style

Gad, D., Elhaak, M., Pompa, A., Mattar, M., Zayed, M., Fraternale, D., & Dietz, K. -J. (2020). A New Strategy to Increase Production of Genoprotective Bioactive Molecules from Cotyledon-Derived Silybum marianum L. Callus. Genes, 11(7), 791. https://doi.org/10.3390/genes11070791

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop